Abbott Labs Ready for its Quarterly Earnings Release

Published on Tuesday, 24 January 2012 10:00 Written by Christopher Lynn

New York, January 24th (TradersHuddle.com) - Shares of Abbott Laboratories (NYSE:ABT) are trading higher by +0.38% ahead of its quarterly earnings release. Abbott Labs, the maker of diversified health care products is expected to release its quarterly results on January 25^th.

Wall Street Analysts consensus calls for a profit of $1.44 a share on $10.61 billion revenue.

Abbott Labs estimates have a range of $0.08 a share. The high estimate calls for profit of $1.45 a share and the low estimate is calling for a profit of $1.37 a share, a year ago for the quarter the company reported $1.3 a share.

Abbott Laboratories (NYSE:ABT) develops, manufactures, and sells a broad and diversified line of health care products and services. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors. The company was founded in 1888 and is based in Abbott Park, Illinois.